Citations

Clear

513 citation(s) found for "Ta, Casey".

Severe Pediatric Neurological Manifestations With SARS-CoV-2 or MIS-C Hospitalization and New Morbidity
Francoeur, Conall , Robertson, Courtney , Wainwright, Mark S. , Roa, Juan D. , Lovett, Marlina E. , Stulce, Casey , Yacoub, M, Potera, Renee M. , Zivick, Elizabeth, Holloway, Adrian , Nagpal, Ashish, Even, Katelyn , Rodriguez, Isadora Souza , Walker, Tracie C. , Campos-Miño, Santiago , Sewell, Taylor B. , Pryce, Patrice , Silver, Wendy G. , Lin, Jieru E. , Vargas, Wendy , McGuire, Jennifer L. , Tasayco-Muñoz, Jaime , Hong, Sue J. , Doerfler, Matthew , Williams, Cydni N. , Drury, Kurt , Bhagat, Dhristie, Price, Dana C. , Santos, Laura Jurema dos , Kahoud, Robert J., Agner, Shannon C. , Walson, Karen, Rasmussen, Lindsey , Pal, Ria , Janas, Anna , Ferrazzano, Peter , Farias‐Moeller, Raquel , Snooks, Kellie , Chang, Chung‐Chou H. , Iolster, Tomás, Erklauer, Jennifer , Yoong, Michael , Jardine, Michelle, Mohammad, Zoha, Deep, Akash , Kendirli, Tanıl , Lidsky, Karen , Dallefeld, Samantha , Flockton, Helen, Agrawal, Shruti , Siruguppa, K., Gutiérrez-Mata, Alfonso, Bogantes-Ledezma, Sixto , Sevilla-Acosta, Fabricio , Umaña-Calderón, Andrés , Ulate-Campos, Adriana , Talisa, Victor B. , Kanthimathinathan, Hari Krishnan , Schober, Michelle E. , Kahoud, Robert, Wainwright, Mark S , Alcamo, Alicia M. , Yacoub, Mais, Wellnitz, Kari , Carvalho, Werther Brunow de , Schwartz, Stephanie P. , Dervan, Leslie A. , Geneslaw, Andrew S. , Topjian, Alexis , Domínguez-Rojas, Jesús , Muller, William J. , Nelson, Aaron L.A. , Price, Dana, Dapul, Heda , Appavu, Brian , Guilliams, Kristin P. , Barón, Facundo Jorro , Wassmer, Evangeline , Waak, Michaela , Butt, Warwick W. , Yock‐Corrales, Adriana , Fink, Ericka L.

Mayo Clinic

JAMA Network Open | June 10, 2024 | Volume: 7 | Issue: 6 | Pages: e2414122

10.1001/jamanetworkopen.2024.14122 | PMID 38857050 Get It

Importance Neurological manifestations during acute SARS-CoV-2–related multisystem inflammatory syndrome in children (MIS-C) are common in hospitalized patients younger than 18 years and may increase risk of new neurocognitive or functional morbidity. Objective To assess the association of severe neurological manifestations during a SARS-CoV-2–related hospital admission with new neurocognitive or functional morbidities at discharge. Design, Setting, and Participants This prospective cohort study from 46 centers in 10 countries included patients younger than 18 years who were hospitalized for acute SARS-CoV-2 or MIS-C between January 2, 2020, and July 31, 2021. Exposure Severe neurological manifestations, which included acute encephalopathy, seizures or status epilepticus, meningitis or encephalitis, sympathetic storming or dysautonomia, cardiac arrest, coma, delirium, and stroke. Main Outcomes and Measures The primary outcome was new neurocognitive (based on the Pediatric Cerebral Performance Category scale) and/or functional (based on the Functional Status Scale) morbidity at hospital discharge. Multivariable logistic regression analyses were performed to examine the association of severe neurological manifestations with new morbidity in each SARS-CoV-2–related condition. Results Overall, 3568 patients younger than 18 years (median age, 8 years [IQR, 1-14 years]; 54.3% male) were included in this study. Most (2980 [83.5%]) had acute SARS-CoV-2; the remainder (588 [16.5%]) had MIS-C. Among the patients with acute SARS-CoV-2, 536 (18.0%) had a severe neurological manifestation during hospitalization, as did 146 patients with MIS-C (24.8%). Among survivors with acute SARS-CoV-2, those with severe neurological manifestations were more likely to have new neurocognitive or functional morbidity at hospital discharge compared with those without severe neurological manifestations (27.7% [n = 142] vs 14.6% [n = 356]; P < .001). For survivors with MIS-C, 28.0% (n = 39) with severe neurological manifestations had new neurocognitive and/or functional morbidity at hospital discharge compared with 15.5% (n = 68) of those without severe neurological manifestations ( P = .002). When adjusting for risk factors in those with severe neurological manifestations, both patients with acute SARS-CoV-2 (odds ratio, 1.85 [95% CI, 1.27-2.70]; P = .001) and those with MIS-C (odds ratio, 2.18 [95% CI, 1.22-3.89]; P = .009) had higher odds of having new neurocognitive and/or functional morbidity at hospital discharge. Conclusions and Relevance The results of this study suggest that children and adolescents with acute SARS-CoV-2 or MIS-C and severe neurological manifestations may be at high risk for long-term impairment and may benefit from screening and early intervention to assist recovery.
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer
Drew, David A. , Kim, Andre E. , Lin, Yi , Morrison, John L. , Lewinger, Juan Pablo , Fu, Yubo, Zemlianskaia, Natalia , Díez‐Obrero, Virginia , Baurley, James W. , Wu, Anna H. , Prentice, Ross L. , Harlid, Sophia , Barry, Elizabeth L. , Berndt, Sonja I. , Bouras, Emmanouil , Burnett‐Hartman, Andrea N. , Casey, Graham , Chang‐Claude, Jenny , Figueiredo, Jane C. , Gruber, Stephen B. , Gsur, Andrea , Harrison, Tabitha A. , Huyghe, Jeroen R. , Jordahl, Kristina M. , Kundaje, Anshul , Li, Li , Newton, Christina C. , Obón‐Santacana, Mireia , Pai, Rish K. , Papadimitriou, Nikos , Scacheri, Peter C. , Schmit, Stephanie L. , Thomas, Duncan C. , Duijnhoven, Fränzel J.B. van , Guelpen, Bethany Van , Peters, Ulrike , Gauderman, W. James , Morrison, John L , Lewinger, Juan Pablo , Wang, Jun , Zemlianskaia, Natalia , Bien, Stephanie A , Dimou, Niki , Buchanan, Daniel D , Potter, John D , Prentice, Ross L , Harlid, Sophia , Arndt, Volker , Bouras, Emmanouil , Carreras-Torres, Robert , Casey, Graham , Devall, Matthew A M , Gruber, Stephen B , Gsur, Andrea , Gunter, Marc J , Harrison, Tabitha A , Hoffmeister, Michael , Huyghe, Jeroen R , Jenkins, Mark A , Jordahl, Kristina M , Kundaje, Anshul , Li, Li , Lynch, Brigid M , Nassir, Rami , Newton, Christina C , Ogino, Shuji , Ose, Jennifer , Pai, R K , Palmer, Julie R , Pardamean, Bens , Pellatt, Andrew J , Peoples, Anita R , Platz, Elizabeth A. , Rennert, Gad , Ruiz-Narvaez, Edward , Sakoda, Lori C , Schmit, Stephanie L , Schoen, Robert E , Su, Yu-Ru , Tian, Yu , Tsilidis, Konstantinos K , Ulrich, Cornelia M , Um, Caroline Y , van Duijnhoven, Fränzel J B , Van Guelpen, Bethany , Hsu, Li , Moreno, Victor , Peters, Ulrike , Chan, Andrew T , Gauderman, W James , Drew, David A , Obón-Santacana, Mireia , Papadimitriou, Nikos , Diez-Obrero, Virginia , Qu, Conghui , Kawaguchi, Eric , Bien, Stephanie A. , Dimou, Niki , Albanes, Demetrius , Buchanan, Daniel D. , Potter, John D. , Arndt, Volker , Brenner, Hermann , Budiarto, Arif , Campbell, Peter T. , Carreras‐Torres, Robert , Conti, David V. , Gunter, Marc J. , Hidaka, Akihisa , Hoffmeister, Michael , Jenkins, Mark A. , Marchand, Loı̈c Le , Murphy, Neil , Nassir, Rami , Newcomb, Polly A. , Ose, Jennifer , Palmer, Julie R. , Pardamean, Bens , Pellatt, Andrew J. , Rennert, Gad , Sakoda, Lori C. , Schoen, Robert E. , Stern, Mariana Carla , Tian, Yu , Tsilidis, Konstantinos K. , Ulrich, Cornelia M. , Um, Caroline Y. , White, Emily E. , Moreno, Vı́ctor , Chan, Andrew T.

Mayo Clinic

Science Advances | May 29, 2024 | Volume: 10 | Issue: 22 | Pages: No page available

10.1126/sciadv.adk3121 | PMID 38809988 Get It

Regular, long-term aspirin use may act synergistically with genetic variants, particularly those in mechanistically relevant pathways, to confer a protective effect on colorectal cancer (CRC) risk. We leveraged pooled data from 52 clinical trial, cohort, and case-control studies that included 30,806 CRC cases and 41,861 controls of European ancestry to conduct a genome-wide interaction scan between regular aspirin/nonsteroidal anti-inflammatory drug (NSAID) use and imputed genetic variants. After adjusting for multiple comparisons, we identified statistically significant interactions between regular aspirin/NSAID use and variants in 6q24.1 (top hit rs72833769 ), which has evidence of influencing expression of TBC1D7 (a subunit of the TSC1-TSC2 complex, a key regulator of MTOR activity), and variants in 5p13.1 (top hit rs350047 ), which is associated with expression of PTGER4 (codes a cell surface receptor directly involved in the mode of action of aspirin). Genetic variants with functional impact may modulate the chemopreventive effect of regular aspirin use, and our study identifies putative previously unidentified targets for additional mechanistic interrogation.
Ethanol disrupts hepatocellular lipophagy by altering Rab5-centric LD-lysosome trafficking
Schott, Micah B. , Rozeveld, Cody N., Bhatt, Saumya , Crossman, Bridget, Krueger, Eugene W. , Weller, Shaun G. , Rasineni, Karuna , McNiven, Mark A. , Schott, Micah B , Crossman, Bridget E. , Casey, Carol A.

Mayo Clinic

Hepatology Communications | May 23, 2024 | Volume: 8 | Issue: 6 | Pages: No page available

10.1097/hc9.0000000000000446 | PMID 38780316 Get It

Background:Previous reports suggest that lipid droplets (LDs) in the hepatocyte can be catabolized by a direct engulfment from nearby endolysosomes (microlipophagy). Further, it is likely that this process is compromised by chronic ethanol (EtOH) exposure leading to hepatic steatosis. This study investigates the hepatocellular machinery supporting microlipophagy and EtOH-induced alterations in this process with a focus on the small, endosome-associated, GTPase Rab5.Methods and Results:Here we report that this small Ras-related GTPase is a resident component of LDs, and its activity is important for hepatocellular LD-lysosome proximity and physical interactions. We find that Rab5 siRNA knockdown causes an accumulation of LDs in hepatocytes by inhibiting lysosome dependent LD catabolism. Importantly, Rab5 appears to support this process by mediating the recruitment of early endosomal and or multivesicular body compartments to the LD surface before lysosome fusion. Interestingly, while wild-type or a constituently active GTPase form (Q79L) of Rab5 supports LD-lysosome transport, this process is markedly reduced in cells expressing a GTPase dead (S34N) Rab5 protein or in hepatocytes exposed to chronic EtOH.Conclusions:These findings support the novel premise of an early endosomal/multivesicular body intermediate compartment on the LD surface that provides a “docking” site for lysosomal trafficking, not unlike the process that occurs during the hepatocellular degradation of endocytosed ligands that is also known to be compromised by EtOH exposure.
Impact of Chloride-Rich Crystalloids on Sepsis-Associated Communi-ty-Acquired AKI Recovery in Critically Ill Patients
Frazee, Erin N. , Tehranian, Shahrzad , Shawwa, Khaled , Clements, Casey M. , Kashani, Kianoush

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 77-77

10.1681/asn.20203110s177c Get It

Reducing Chronic Opioid Use
Gupta, Nikita, Lee, Yeonsoo Sara , Abujbarah, Sami , Casey, William J., Pockaj, Barbara A. , Jogerst, Kristen, Lee, Yeonsoo S, Casey, William, Pockaj, Barbara, Sara Lee, Yeonsoo , Jogerst, Kristen M. , Gupta, Nikita, Kosiorek, Heidi , Cronin, Patricia A.

Mayo Clinic

Annals of Surgery | May 17, 2024 | Volume: 281 | Issue: 5 | Pages: 787-795

10.1097/sla.0000000000006344 | PMID 38757265 Get It

Objective: This study investigates Enhanced Recovery After Surgery (ERAS) protocols’ impact on long-term opioid and sedative use following mastectomy with or without implant-based breast reconstruction (IBBR). Background: ERAS protocols for patients undergoing mastectomy with or without IBBR are associated with decreased length of stay, increased rate of same-day discharge, decreased postoperative pain, and decreased postoperative opioid requirements. However, less is known about their effect on opioid and sedative use beyond 90 days after surgery. Methods: A retrospective review of all patients undergoing mastectomy with or without IBBR at a single institution between January 2013 and December 2019. Mastectomy ERAS protocols were implemented in February 2017, creating 2 groups: pre-ERAS and ERAS. Baseline characteristics and prevalence of chronic opioid and sedative use were compared. Univariable and multivariable logistic regression predicted factors associated with increased odds of chronic opioid and sedative use. Results: A total of 756 patients were evaluated: 405 pre-ERAS and 351 ERAS. Post-ERAS, chronic opioid use decreased in opioid-naive (40% vs 30%, P=0.024) and opioid-tolerant patients (58% vs 37%, P=0.002), with no increase in chronic sedative use. There were decreased odds of chronic opioid use for all ERAS patients (OR=0.57, 95% CI: 0.42–0.76), and of IBBR patients, those receiving subcutaneous implants (OR=0.31, 95% CI: 0.20–0.48). There was increased chronic opioid-use odds if undergoing bilateral surgery (OR=1.54, 95% CI: 1.14–2.08), 2-stage reconstruction (OR=9.78, 95% CI: 5.94-16.09), and for patients with higher PACU pain scores (OR=1.09, 95% CI: 1.03–1.14) or >150 discharge OMEs (OR=2.63, 95% CI: 1.48–4.68). Conclusion: ERAS protocols for mastectomy patients with or without IBR are associated with decreases in chronic opioid use, without concomitant increases in chronic sedative use.
Volumetric Analysis of a Novel Chimeric Gracilis and Profunda Artery Perforator Flap
Spronsen, Nicole Van , Plonkowski, Alexander T. , Jokerst, Clint , Shrout, Max A., Reece, Edward, Casey, William J., Rebecca, Alanna M. , Van Spronsen, Nicole R, Reece, Edward M., Hammond, Jacob B. , Flug, Jonathan A.

Mayo Clinic

Journal of Reconstructive Microsurgery | May 6, 2024 | Volume: 41 | Issue: 01 | Pages: 063-067

10.1055/a-2320-5489 | PMID 38710225 Get It

Abstract Background The presence of a chimeric gracilis and profunda artery perforator (PAP) flap with a common arterial pedicle has been demonstrated on computed tomography angiography in up to 59% of patients and confirmed in a cadaveric model. Already utilized for head and neck reconstruction by Heredero et al, this novel flap could provide more volume than either flap alone which is advantageous, particularly in patients with sizable defects. The purpose of this study was to determine the average tissue volume that can be utilized from this chimeric flap. Methods CT Angiogram imaging studies exhibiting chimeric flap anatomy were reviewed over a 7-year period at a single institution utilizing Visage Version 7.1, a radiology picture archiving and communication system. This software was used to trace the flap pedicles and to capture estimated soft tissue volumes of each respective flap. Results A total of 31 patients, consisting of 52 lower extremity gracilis and PAP chimeric flaps, underwent tissue volume analysis. The average total volume of soft tissue supplied by the gracilis flap was found to be 70.21 cm3 (standard deviation [SD] = 26.99). The average volume of the PAP flap was 31.73 cm3 (SD = 26.12). The average total volume captured by the chimeric gracilis and PAP flap was 101.94 cm3 (SD = 62.40). Conclusion The potential soft tissue volume that can be harvested from a chimeric gracilis and PAP flap is significantly greater than solitary gracilis or PAP flaps. This chimeric flap may serve as a viable and advantageous reconstructive option for patients requiring large volume soft tissue coverage, particularly if other sizable options are not available.
COVID-19 and renal allograft rejection: insight from controlled and non-controlled studies
Soliman, Karim , Salas, Maria Aurora Posadas , Uehara, Genta, Vaishnav, Sakshi, Cheungpasitporn, Wisit , Casey, Michael J. , Cheungpasitporn, Wisit , Soliman, Karim M , Daoud, Ahmed

Mayo Clinic

Renal Failure | April 17, 2024 | Volume: 46 | Issue: 1 | Pages: No page available

10.1080/0886022x.2024.2336126 | PMID 38627208 Get It

Gaps in Acute Treatment Optimization in Participants with Migraine: Results from the US Cohort of the Chronic Migraine Epidemiology and Outcomes—International (CaMEO-I) Study (S22.003)
Buse, Dawn C. , Hutchinson, Susan , Fanning, Kristina M. , Schlacher, Casey, Lama, Janette Contreras‐De, Schwedt, Todd J. , Lipton, Richard B.

Mayo Clinic

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206278 Get It

What Makes a Tweetorial Fly? (S33.009)
Albin, Casey, Pucci, Gabriela, Zelikovich, Aaron, Lawson, Eric C. , Ma, Tianwen , Dangayach, Neha , Berkowitz, Aaron, Ma, Tianwen, Sarwal, Aarti , Morris, Nicholas A. , Jones, Lyell K.

Mayo Clinic

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206156 Get It